8.49
price up icon0.11%   0.0096
after-market Dopo l'orario di chiusura: 8.50 0.010 +0.12%
loading
Precedente Chiudi:
$8.4804
Aprire:
$7.6
Volume 24 ore:
17,029
Relative Volume:
1.51
Capitalizzazione di mercato:
$72.67M
Reddito:
-
Utile/perdita netta:
$-53.45M
Rapporto P/E:
-0.3911
EPS:
-21.71
Flusso di cassa netto:
$-31.81M
1 W Prestazione:
+6.60%
1M Prestazione:
-18.66%
6M Prestazione:
-30.41%
1 anno Prestazione:
-22.82%
Intervallo 1D:
Value
$7.60
$8.695
Intervallo di 1 settimana:
Value
$7.45
$8.695
Portata 52W:
Value
$5.90
$18.17

Surrozen Inc Stock (SRZN) Company Profile

Name
Nome
Surrozen Inc
Name
Telefono
650-475-2820
Name
Indirizzo
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Name
Dipendente
41
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-16
Name
Ultimi documenti SEC
Name
SRZN's Discussions on Twitter

Confronta SRZN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SRZN
Surrozen Inc
8.49 68.20M 0 -53.45M -31.81M -21.71
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Surrozen Inc Stock (SRZN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-30 Iniziato H.C. Wainwright Buy
2025-01-03 Aggiornamento Guggenheim Neutral → Buy
2021-10-11 Iniziato BofA Securities Buy
2021-09-15 Iniziato Guggenheim Buy
2021-09-07 Iniziato Stifel Buy

Surrozen Inc Borsa (SRZN) Ultime notizie

pulisher
May 20, 2025

Surrozen (SRZN) Files for $150 Million Mixed Securities Offering - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Surrozen (SRZN) Files for $150 Million Mixed Securities Offering | SRZN Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Surrozen Inc Files For Mixed Shelf Of Up To $150 MillionSEC Filing - marketscreener.com

May 20, 2025
pulisher
May 16, 2025

(SRZN) Proactive Strategies - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Down -29.72% in 4 Weeks, Here's Why Surrozen (SRZN) Looks Ripe for a Turnaround - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Surrozen Holds Successful 2025 Annual Stockholders Meeting - TipRanks

May 15, 2025
pulisher
May 14, 2025

Surrozen secures patent for tissue repair technology By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Surrozen granted patent from USPTO directed to antibody-based molecules - TipRanks

May 14, 2025
pulisher
May 14, 2025

Surrozen (SRZN) Secures New U.S. Patent for Innovative SWAPTM Te - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Surrozen secures patent for tissue repair technology - Investing.com

May 14, 2025
pulisher
May 14, 2025

Breakthrough Patent: Surrozen's New Wnt Technology Could Transform Tissue Repair Therapeutics - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Surrozen’s (SRZN) Buy Rating Reaffirmed at HC Wainwright - Defense World

May 13, 2025
pulisher
May 12, 2025

Surrozen (SRZN) Receives Continued "Buy" Rating from HC Wainwright | SRZN Stock News - GuruFocus

May 12, 2025
pulisher
May 10, 2025

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 10, 2025
pulisher
May 10, 2025

Surrozen, Inc. Reports Q1 2025 Financial Results - TipRanks

May 10, 2025
pulisher
May 09, 2025

Surrozen, Inc. Reports First Quarter 2025 Financial Results and Business Update Focused on Ophthalmology Pipeline - Nasdaq

May 09, 2025
pulisher
May 09, 2025

CyberCatch Announces Cybersecurity Solution To Protect Thousands of Drinking Water Systems in U.S. that EPA OIG Report Reveals are at Risk of Cyber Attack with One-Day Disruption Cost of $43.5 Billion - The Globe and Mail

May 09, 2025
pulisher
May 09, 2025

BestGrowthStocks.Com Issues a Comprehensive Analysis of Richtech Robotics - The Globe and Mail

May 09, 2025
pulisher
May 07, 2025

Surrozen’s SZN-8141 ameliorates retinopathy in murine models - BioWorld MedTech

May 07, 2025
pulisher
May 06, 2025

Trend Tracker for (SRZN) - news.stocktradersdaily.com

May 06, 2025
pulisher
Apr 24, 2025

Surrozen files to sell 5.21M shares of common stock for holders - MSN

Apr 24, 2025
pulisher
Apr 04, 2025

When (SRZN) Moves Investors should Listen - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 02, 2025

Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Insiders Are Loving These 5 Tech and Biotech Stocks - 24/7 Wall St.

Apr 02, 2025
pulisher
Apr 02, 2025

Surrozen (SRZN) to Release Earnings on Wednesday - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Surrozen Focuses on Ophthalmology Amid Financial Challenges - TipRanks

Apr 02, 2025
pulisher
Apr 01, 2025

Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates - The Manila Times

Apr 01, 2025
pulisher
Mar 31, 2025

Surrozen Lands Massive $175M Deal: What This Means for Its Eye Disease Pipeline - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Friday’s Insider Moves: Major Buys in Insurance and Biotech, Sells in Energy - Investing.com Australia

Mar 31, 2025
pulisher
Mar 29, 2025

Surrozen sees $11.9 million in stock purchases by Column Group - Investing.com UK

Mar 29, 2025
pulisher
Mar 28, 2025

Surrozen Secures $76.4M in Private Placement Deal - TipRanks

Mar 28, 2025
pulisher
Mar 25, 2025

Surrozen drops hepatitis drug after Phase I flop - Yahoo

Mar 25, 2025
pulisher
Mar 24, 2025

Surrozen shifts focus to eye disease treatments, secures $175M funding - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Surrozen Secures $175Mln In Oversubscribed Private Placement To Advance Ophthalmology Pipeline - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Surrozen to Raise Up to $175 Million in Private Placement; Fine-Tunes Ophthalmology Clinical Programs - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund - Endpoints News

Mar 24, 2025
pulisher
Mar 24, 2025

Surrozen shifts focus to eye disease treatments, secures $175M funding By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Surrozen, Inc. Prioritizes Ophthalmology Pipeline with $175 Million Financing and Discontinues SZN-043 Development - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases - The Manila Times

Mar 24, 2025
pulisher
Mar 24, 2025

Major Pivot: Surrozen Lands $175M to Develop Breakthrough Eye Disease Treatments - Stock Titan

Mar 24, 2025
pulisher
Mar 14, 2025

(SRZN) Trading Advice - Stock Traders Daily

Mar 14, 2025
pulisher
Mar 10, 2025

Reviewing Surrozen (NASDAQ:SRZN) & Tenaya Therapeutics (NASDAQ:TNYA) - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Wnt efforts condensing at Dewpoint, Surrozen, more - BioWorld MedTech

Mar 07, 2025
pulisher
Mar 03, 2025

(SRZN) On The My Stocks Page - Stock Traders Daily

Mar 03, 2025
pulisher
Mar 03, 2025

Week Ahead (Sep.13- 17): FDA Decision, Data Readouts (CALT, ASLN, LIFE…) - RTTNews

Mar 03, 2025
pulisher
Feb 26, 2025

Better Warren Buffett Stock: Nu Holdings vs. Bank of America - The Globe and Mail

Feb 26, 2025
pulisher
Feb 21, 2025

(SRZN) Trading Signals - Stock Traders Daily

Feb 21, 2025
pulisher
Feb 12, 2025

H.C. Wainwright sets $32 target on Surrozen stock with Buy rating - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

MicroStrategy Is Rebranding to ‘Strategy.’ Should You Buy, Sell, or Hold MSTR Stock? - The Globe and Mail

Feb 12, 2025

Surrozen Inc Azioni (SRZN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):